Dia Beta Labs

Developer of novel therapeutic peptides for metabolic disease treatment

placeBelfast, Northern Ireland, United Kingdom calendar_todayFounded 2022 language diabetalabs.com

Registered entities

Innovation

1 patent family — focus: Human necessities; filing pace active.

YearFilings
20241
20251
20261

Social engagement

Social engagement: 731 social following, 5 posts in the last 12 months — top 10% of its industry.

Investor mix

5 investors on record; lead investors include DSW Ventures.

Investor typeCountShare
Venture capital120%
Accelerator & incubator120%
Other / undisclosed360%

Recent activity

31 Oct 2025
Event
BIO Europe
8 Sep 2025
Leadership hire
Senior Project Manager
3 Sep 2025
Recognition
regulatory
Coming soon